Pegex (Pegfilgrastim) Injection
Generic API Name:Pegfilgrastim. Generic Branded Name: Pegex is available in India. It is used for the treatment of febrile neutropenia and to increase the survival rate in patients receiving myelosuppressive doses of radiation. Pegex is used to manage the destruction of white blood cells (WBC) in blood that is caused due to chemotherapy . It reduces the occurrence of neutropenia (low WBC count in blood) and febrile neutropenia (low WBC count in blood with fever) among patients receiving chemotherapy. Generic brands for Pegfilgrastim 6mg Injection Available in India Brand Name Pegex Generic Name Pegfilgrastim 6mg Strength 6Mg Manufacturer Emcure Pharma ltd. What is the cost of Pegfilgrastim in India? Place your order today to receive authentic medications, enjoy maximum discounts on medicin
About Pegex (Pegfilgrastim) Injection
Description Pegfilgrastim is a hematopoietic drug, it is sold under the brand name Pegex. It it used for the treatment of febrile neutropenia and to increase the survival rate in patients receiving myelosuppressive doses of radiation. It is a PEGylated form of the recombinant human granulocyte colony-stimulating factor (GCSF) analog filgrastim. It serves to stimulate the production of white blood cells (neutrophils). Pegfilgrastim was approved for medical use in the United States in January 2002, in the European Union in August 2002, and in Australia in September 2002. List of available brand-name drugs in India for Pegfilgrastim Branded Generic Drugs for Pegfilgrastim: Neupeg, Pegex, Peg-Grafeel, Peg Religrast, Peg, Glenstim, Pegg Frastim, Pegstim, Pegg Trust, Pegasta NEWS / Updates Package leaflet: Information for the user Neulasta 6 mg solution for injection pegfilgrastim. [Revised 2021 Jun] [cited 2023 Feb 23]. Available from: https://www.medicines.org.uk/emc/files/pil.10091.pdf Patient Information Neulasta ® (nu-las-tah) (pegfilgrastim) injection Single-Dose Prefilled Syringe. (2021). Available at: https://www.pi.amgen.com/-/media/Project/Amgen/Repository/pi-amgen-com/Neulasta/neulasta_ppi_pt_english.pdf [Accessed 23 Feb. 2023]. HIGHLIGHTS OF PRESCRIBING INFORMATION. (2019). Available at: https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/125031s198lbl.pdf [Accessed 23 Feb. 2023]. Parker, S.D. and Jacobs, T.F. (2020). Pegfilgrastim . [online] PubMed. Available at: https://www.ncbi.nlm.nih.gov/books/NBK532893/ [Accessed 23 Feb. 2023]. Written By Mr. Sandeep Tomar (D. pharma) Last updated 26 Sep 2024 | 05:03 AM (IST)
